Published in Medical Letter on the CDC and FDA, February 22nd, 1999
VaxGen Inc., Brisbane, California, said 2,500 Thais at high risk for HIV would be recruited for the trial of the AIDSVAX vaccine, which has been tailored to work against the strain of HIV seen most commonly in Asia.
"This is the next step around the world," said Dr. Donald Francis, VaxGen and former director of the U.S. Centers for Disease Control and Prevention's (CDC) AIDS efforts. "No one can ignore 16,000 new infections a day of a virus that has essentially 100 percent mortality, and the only way it's going to be stopped is a vaccine. Everyone in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.